Company profile for SK Bioscience

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Signed an agreement with Sanofi Pasteur to license out cell-culture technology for producing cell culture-derived influenza vaccines. Established SK Bioscience. Launched Sky Zoster Inj., world’s second shingles vaccine Signed an agreement with international organization PATH to develop and produce pediatric enteritis vaccine for developing countries Launched SKYCellflu Quadrivalent, world’s first quadrivalent cell culture...
Signed an agreement with Sanofi Pasteur to license out cell-culture technology for producing cell culture-derived influenza vaccines. Established SK Bioscience. Launched Sky Zoster Inj., world’s second shingles vaccine Signed an agreement with international organization PATH to develop and produce pediatric enteritis vaccine for developing countries Launched SKYCellflu Quadrivalent, world’s first quadrivalent cell culture-derived influenza vaccine. Gained approval for SKYPNEUMO, the first domestically produced PCV13 vaccine. Launched SKYCellflu, Korea’s first trivalent cell culture-derived influenza vaccine

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
310 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do (13494)
Telephone
Telephone
+82-2-2008-2200
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/idt-biologika-accelerates-global-cdmo-expansion-manufacturing-capabilities-highlighted-through-consecutive-participation-in-wvc-cphi-and-bio-europe-2025-302605150.html

PR NEWSWIRE
05 Nov 2025

https://www.businesswire.com/news/home/20250918284081/en/Sunflower-Therapeutics-Receives-First-Milestone-Payment-Through-Collaboration-with-SK-bioscience-on-Cost-Effective-HPV-Vaccine

BUSINESSWIRE
18 Sep 2025

https://www.fiercepharma.com/pharma/sks-blockbuster-hopeful-xcopri-reduces-seizures-phase-3-trial-teeing-fda-expansion-bid

FIERCE PHARMA
17 Sep 2025

https://www.prnewswire.com/news-releases/sk-bioscience-submits-ind-for-phase-3-trial-of-2-dose-varicella-vaccine-reflecting-global-standard-shift-302543577.html

PR NEWSWIRE
02 Sep 2025

https://www.prnewswire.com/news-releases/sk-bioscience-discusses-further-collaboration-with-the-gates-foundation-to-advance-global-health-302535617.html

PR NEWSWIRE
21 Aug 2025

https://www.prnewswire.com/news-releases/sk-bioscience-submits-ind-for-phase-12-clinical-trial-of-adjuvanted-influenza-vaccine-candidate-302506731.html

PR NEWSWIRE
17 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty